Historical record - last NADAC effective date: 1/3/2020
Product Information
SANDIMMUNE 100 MG CAPSULE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $15.3370 per EA under NDC 00078024115. Its NADAC has been published 373 times since Nov 28, 2013.
FDA first approved this application on Mar 2, 1990. Its Orange Book therapeutic-equivalence code is BX.
Strength
100 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078024115
Classification
Brand
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
1/3/2020
Active Ingredients
CYCLOSPORINEApproval Type
New Drug (NDA)
FDA Application
NDA050625FDA Approved
3/2/1990
TE Code
BX
On Market Since
3/2/1990
Pharmacological Classes
Price Statistics
The NADAC for SANDIMMUNE 100 MG CAPSULE has been published 373 times since Nov 28, 2013, and over the history we have for it it has risen 52.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.3370 per EA |
|---|---|
| All-time high | $15.3370 (Jan 13, 2021) |
| All-time low | $10.0424 (Nov 28, 2013) |
| Median price | $13.1890 |
| Average price | $13.0206 |
| Largest weekly change | +5.5% (Jan 15, 2020) |
| Weeks tracked | 373 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+52.7%
Last surveyed Jan 13, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novartis Pharmaceuticals Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
cyclosporine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcineurin Inhibitor Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SANDIMMUNE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for SANDIMMUNE 100 MG CAPSULE, manufactured by Novartis Pharmaceuticals Corporation, is $15.3370 per EA (NDC 00078024115), effective Jan 13, 2021.
How has the price of SANDIMMUNE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for SANDIMMUNE 100 MG CAPSULE has risen 52.7%. It has been tracked across 373 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SANDIMMUNE 100 MG CAPSULE?
Since Nov 28, 2013, the NADAC for SANDIMMUNE 100 MG CAPSULE has ranged from a low of $10.0424 (Nov 28, 2013) to a high of $15.3370 (Jan 13, 2021), with a median of $13.1890 per EA.
Are there cheaper alternatives to SANDIMMUNE 100 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NEORAL 100 MG GELATIN CAPSULE, is $11.7731 per EA — about 23% below SANDIMMUNE 100 MG CAPSULE.
Who manufactures SANDIMMUNE 100 MG CAPSULE?
SANDIMMUNE 100 MG CAPSULE (NDC 00078024115) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.